Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real-World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next Steps

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. 

In a recent publication, Cresswell et al. reviewed global regulatory and HTA policies on real-world evidence (RWE) use. The authors aimed to identify best practices and policy gaps to support more consistent adoption of RWE in decision-making. The findings highlighted growing momentum toward standardization but revealed persistent inconsistencies in acceptance and use across jurisdictions, underscoring the need to better align methodological and policy frameworks.

Access the full-text article here.